US Patent 9951144 Antibody therapeutics that bind CD38
Patent 9951144 was granted and assigned to Sorrento Therapeutics on April, 2018 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 8, 2016
Date of Patent
April 24, 2018
Patent Applicant
Patent Application Number
15093773
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9951144 Antibody therapeutics that bind CD38
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.